日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.

Tebentafusp 可诱导葡萄膜黑色素瘤患者产生由细胞毒性 T 细胞驱动的靶向皮肤免疫反应

Staeger Ramon, Tastanova Aizhan, Ghosh Adhideb, Winkelbeiner Nicola, Shukla Prachi, Kolm Isabel, Turko Patrick, Benlahrech Adel, Harper Jane, Broomfield Anna, Camera Antonio, Ambrosio Marianna, Haunerdinger Veronika, Cheng Phil F, Ramelyte Egle, Pham James, Kreutmair Stefanie, Becher Burkhard, Levesque Mitchell P, Dummer Reinhard, Meier-Schiesser Barbara

The serum metabolome serves as a diagnostic biomarker and discriminates patients with melanoma from healthy individuals

血清代谢组可作为诊断生物标志物,用于区分黑色素瘤患者和健康个体。

Morsy, Yasser; Hubeli, Barbara; Turko, Patrick; Barysch, Marjam; Martínez-Gómez, Julia M; Zamboni, Nicola; Rogler, Gerhard; Dummer, Reinhard; Levesque, Mitchell P; Scharl, Michael

p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.

p62 mRNA 通过 miR-34a-5p 抑制皮肤 SCC 细胞中 NLRP1 的表达

Hennig Paulina, Turko Patrick, Di Filippo Michela, Levesque Mitchell P, Kündig Thomas, Beer Hans-Dietmar

Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted

免疫相关皮肤不良事件表现出不同的临床和分子特征,这取决于靶向的免疫检查点。

Kraehenbuehl, Lukas; Winkelbeiner, Nicola; Turko, Patrick; Staeger, Ramon; Ghosh, Adhideb; Kaiser, Vivienn; Stadler, Pia-Charlotte; Nordmann, Thierry M; Brüggen, Marie-Charlotte; Levesque, Mitchell P; Contassot, Emmanuel; French, Lars E; Dummer, Reinhard; Meier-Schiesser, Barbara

Protocol for analysis of miRNAs in human melanoma cells.

人类黑色素瘤细胞中 miRNA 分析方案

Lattmann Evelyn, Guggiari Tessa, Turko Patrick, Levesque Mitchell P

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes

扁平苔藓亚型间基因表达和细胞组成的显著差异

Knoch, Cadri; Baghin, Veronika; Turko, Patrick; Winkelbeiner, Nicola; Staeger, Ramon; Wei, Kongchang; Banzola, Irina; Mellett, Mark; Levesque, Mitchell P; Kuendig, Thomas; French, Lars E; Heinzerling, Lucie; Meier-Schiesser, Barbara

Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland

瑞士一家三级癌症中心单中心研究:晚期黑色素瘤患者临床结果和治疗管理的真实世界数据

Staeger, Ramon; Martínez-Gómez, Julia M; Turko, Patrick; Ramelyte, Egle; Kraehenbuehl, Lukas; Del Prete, Valerio; Hasan Ali, Omar; Levesque, Mitchell P; Dummer, Reinhard; Nägeli, Mirjam C; Mangana, Joanna

Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma

转移性葡萄膜黑色素瘤患者对替苯他福司的放射学反应模式

Roshardt Prieto, Natalia M; Turko, Patrick; Zellweger, Caroline; Nguyen-Kim, Thi Dan Linh; Staeger, Ramon; Bellini, Elisa; Levesque, Mitchell P; Dummer, Reinhard; Ramelyte, Egle

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production

MDM2抑制通过增加IL-15和MHC II类分子的产生来增强免疫检查点抑制剂的疗效。

Langenbach, Marlene; Giesler, Sophie; Richtsfeld, Stefan; Costa-Pereira, Sara; Rindlisbacher, Lukas; Wertheimer, Tobias; Braun, Lukas M; Andrieux, Geoffroy; Duquesne, Sandra; Pfeifer, Dietmar; Woessner, Nadine M; Menssen, Hans D; Taromi, Sanaz; Duyster, Justus; Börries, Melanie; Brummer, Tilman; Blazar, Bruce R; Minguet, Susana; Turko, Patrick; Levesque, Mitchell P; Becher, Burkhard; Zeiser, Robert

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma

时钟样突变特征可能比皮肤黑色素瘤中紫外线损伤特征更能预测更差的生存预后

Fröhlich, Fabienne; Ramelyte, Egle; Turko, Patrick; Dzung, Andreas; Freiberger, Sandra N; Mangana, Joanna; Levesque, Mitchell P; Dummer, Reinhard